Bristol-Myers Squibb (BMY) Tops Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $63.06 +0.35%
Revenue Growth %: +3.2%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +3.2%
Financial Fact:
Net Earnings Attributable to Noncontrolling Interest: 13M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.93 billion versus the consensus estimate of $4.72 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2017 EPS of $2.85-$3.00, versus the consensus of $2.80.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb Co. (BMY) PT Raised to $82 at Piper Sandler
- Amneal gets FDA approval for lanreotide injection, launches immediately
- Forgent Power Solutions, Inc. (FPS) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY27 Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
